ARCHIVES

LAK/IL-2 Therapy Could Halt Kidney Cancer Deaths: DeVita

This article is from The Cancer Letter archive.

Vol. 12 No. 12 | March 21, 1986

Download PDF Visit The Full Archive

Related Articles

NCAB Approves CIS Recompetition, Restructuring

May 17, 1991

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

November 29, 2002

NCI Plans $38 Million For New Research In Tobacco Control Over Next Two Years

October 16, 1998

UICC Grant Programs Available To Support International Activities

April 16, 1976

Preoperative Drug Combo Benefits HER-2 Breast Cancer

April 29, 2005

Senate Authorizes $30 Million For Childhood Cancer Clinical Trials Research.

July 18, 2008